Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

Movement Disorders

Volumn 27, Issue 3, 2012, Pages 349-356

  Litvan, Irene ^a,b   Goldman, Jennifer G ^c   Tröster, Alexander I ^d   Schmand, Ben A ^e,f   Weintraub, Daniel ^g,h   Petersen, Ronald C ⁱ   Mollenhauer, Brit ^j,k   Adler, Charles H ^l   Marder, Karen ^m   Williams Gray, Caroline H ⁿ   Aarsland, Dag ^o,p   Kulisevsky, Jaime ^q,r   Rodriguez Oroz, Maria C ^r,s,t,u   Burn, David J ^v   Barker, Roger A ⁿ   Emre, Murat ^w  

^a University of Louisville School of Medicine   (United States)

^b Movement Disorders Program   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ MAYO CLINIC   (United States)

^j Paracelsus Elena Klinik   (Germany)

^k UNIVERSITY OF GÖTTINGEN   (Germany)

^l MAYO CLINIC   (United States)

^m New York Presbyterian Hospital Columbia University Medical Center   (United States)

ⁿ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^o KAROLINSKA INSTITUTE   (Sweden)

^p AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^q UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^r CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^s HOSPITAL DONOSTIA   (Spain)

^t BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^u BASQUE FOUNDATION FOR SCIENCE   (Spain)

^v NEWCASTLE UNIVERSITY   (United Kingdom)

^w ISTANBUL UNIVERSITY   (Turkey)

more..

Author keywords

Cognition; Dementia; Diagnostic criteria; Mild cognitive impairment; Parkinson's disease

Indexed keywords

ARTICLE; ATTENTION; CLINICAL FEATURE; COMORBIDITY; DISEASE COURSE; EXECUTIVE FUNCTION; HUMAN; LANGUAGE; MEMORY; MILD COGNITIVE IMPAIRMENT; PARKINSON DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; WORKING MEMORY;

HUMANS; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 84858298114     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.24893     Document Type: Article

References (61)

1. Litvan I, Aarsland D, Adler CH, et al. MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 2011; 26: 1814-1824
2. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23: 837-844.
3. Aarsland D, Tandberg E, Larsen JP, Cummings JL. Frequency of dementia in Parkinson disease. Arch Neurol 1996; 53: 538-542.
4. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60: 387-392.
5. Aarsland D, Bronnick K, Williams-Gray C, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010; 75: 1062-1069.
6. Albert MS, Dekosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Alzheimers Dement 2011; 7: 1-10.
7. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194.
8. Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: ten years later. Arch Neurol 2009; 66: 1447-1455.
9. Jeste D, Blacker D, Blazer D, et al. Neurocognitive disorders: a proposal from the DSM-5 Neurocognitive Disorders Work Group, 2010. Available at:
10. Ganguli M, Blacker D, Blazer DG, et al. Classification of neurocognitive disorders in DSM-5: a work in progress. Am J Geriatr Psychiatry 2011; 19: 205-210.
11. Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 2006; 21: 1343-1349.
12. Janvin CC, Aarsland D, Larsen JP. Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study. J Geriatr Psychiatry Neurol 2005; 18: 149-154.
13. Mahieux F, Fenelon G, Flahault A, Manifacier MJ, Michelet D, Boller F. Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 1998; 64: 178-183.
14. Levy G, Jacobs DM, Tang MX, et al. Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord 2002; 17: 1221-1226.
15. Jacobs DM, Marder K, Cote LJ, Sano M, Stern Y, Mayeux R. Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology 1995; 45: 1691-1696.
16. Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov Disord 2004; 19: 1043-1049.
17. Williams-Gray CH, Evans JR, Goris A, et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009; 132: 2958-2969.
18. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-1707.
19. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007; 22: 2314-2324.
20. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
21. Hoops S, Nazem S, Siderowf AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009; 73: 1738-1745.
22. Dalrymple-Alford JC, MacAskill MR, Nakas CT, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 2010; 75: 1717-1725.
23. Villeneuve S, Rodrigues-Brazete J, Joncas S, Postuma RB, Latreille V, Gagnon JF. Validity of the Mattis Dementia Rating Scale to detect mild cognitive impairment in Parkinson's disease and REM sleep behavior disorder. Dement Geriatr Cogn Disord 2011; 31: 210-217.
24. Pagonabarraga J, Kulisevsky J, Llebaria G, Garcia-Sanchez C, Pascual-Sedano B, Gironell A. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Mov Disord 2008; 23: 998-1005.
25. Rossetti HC, Lacritz LH, Cullum CM, Weiner MF. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology 2011; 77: 1272-1275.
26. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991; 59: 12-19.
27. Schinka JA, Loewenstein DA, Raj A, et al. Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates. Am J Geriatr Psychiatry 2010; 18: 684-691.
28. Dalrymple-Alford JC, Livingston L, Macaskill MR, et al. Characterizing mild cognitive impairment in Parkinson's disease. Mov Disord 2011; 26: 629-636.
29. Davis HS, Rockwood K. Conceptualization of mild cognitive impairment: a review. Int J Geriatr Psychiatry 2004; 19: 313-319.
30. Brown RG, MacCarthy B, Jahanshahi M, Marsden CD. Accuracy of self-reported disability in patients with parkinsonism. Arch Neurol 1989; 46: 955-959.
31. Naismith SL, Pereira M, Shine JM, Lewis SJ. How well do caregivers detect mild cognitive change in Parkinson's disease? Mov Disord 2010; 26: 161-164.
32. Caviness JN, Driver-Dunckley E, Connor DJ, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007; 22: 1272-1277.
33. Dujardin K, Dubois B, Tison F, et al. Parkinson's disease dementia can be easily detected in routine clinical practice. Mov Disord 2010; 25: 2769-2776.
34. Bangen KJ, Jak AJ, Schiehser DM, et al. Complex activities of daily living vary by mild cognitive impairment subtype. J Int Neuropsychol Soc 2010; 16: 630-639.
35. Aarsland D, Andersen K, Larsen JP, et al. The rate of cognitive decline in Parkinson disease. Arch Neurol 2004; 61: 1906-1911.
36. Vendette M, Gagnon JF, Decary A, et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology 2007; 69: 1843-1849.
37. Mavandadi S, Nazem S, Ten Have TR, et al. Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease. Am J Geriatr Psychiatry 2009; 17: 986-995.
38. Peralta C, Stampfer-Kountchev M, Karner E, et al. Orthostatic hypotension and attention in Parkinson's disease with and without dementia. J Neural Transm 2007; 114: 585-588.
39. Witjas T, Kaphan E, Azulay JP, et al. Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 2002; 59: 408-413.
40. Lezak MD, Howieson DB, Loring DW.. Neuropsychological Assessment, 4th ed. New York. Oxford University Press: Oxford University Press; 2004.
41. Gazzaniga MS, Ivry RB, Mangun GR. Cognitive Neuroscience: The Biology of the Mind, 3rd ed. New York: W.W. Norton; 2009.
42. Caballol N, Marti MJ, Tolosa E. Cognitive dysfunction and dementia in Parkinson disease. Mov Disord 2007; 22( Suppl 17): S358-S366.
43. Muslimovic D, Schmand B, Speelman JD, de Haan RJ. Course of cognitive decline in Parkinson's disease: a meta-analysis. J Int Neuropsychol Soc 2007; 13: 920-932.
44. Tröster AI. Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers. Neuropsychol Rev 2008; 18: 103-119.
45. Bothe MR, Uttner I, Otto M. Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure. J Neural Transm 2010; 117: 353-367.
46. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004; 127: 550-560.
47. Tröster AI, Woods SP, Morgan EE. Assessing cognitive change in Parkinson's disease: development of practice effect-corrected reliable change indices. Arch Clin Neuropsychol 2007; 22: 711-718.
48. Arbuthnott K, Frank J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clinical Exp Neuropsychology 2000; 22: 518-528.
49. Mollenhauer B, Trenkwalder C. Neurochemical biomarkers in the differential diagnosis of movement disorders. Mov Disord 2009; 24: 1411-1426.
50. Mollenhauer B, Trenkwalder C, von Ahsen N, et al. Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia. Dement Geriatr Cogn Disord 2006; 22: 200-208.
51. Siderowf A, Xie SX, Hurtig H, et al. CSF amyloid {beta> 1-42 predicts cognitive decline in Parkinson disease. Neurology 2010; 75: 1055-1061.
52. Foltynie T, Lewis SG, Goldberg TE, et al. The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease. J Neurol 2005; 252: 833-838.
53. Guerini FR, Beghi E, Riboldazzi G, et al. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease. Eur J Neurol 2009; 16: 1240-1245.
54. Gattellaro G, Minati L, Grisoli M, et al. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. Am J Neuroradiol 2009; 30: 1222-1226.
55. Alves G, Bronnick K, Aarsland D, et al. CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 2010; 81: 1080-1086.
56. Setó-Salvia N, Clarimon J, Pagonabarraga J, et al. Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes. Arch Neurol 2011; 68: 359-364.
57. National Institute of Neurological Disorders and Stroke. NINDS common data elements. 2011. Available at:
58. Gill DJ, Freshman A, Blender JA, Ravina B. The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease. Mov Disord 2008; 23: 1043-1046.
59. Kulisevsky J, Pagonabarraga J. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Mov Disord 2009; 24: 1103-1110.
60. Verbaan D, Marinus J, Visser M, et al. Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 1182-1187.
61. Llebaria G, Pagonabarraga J, Kulisevsky J, et al. Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease. Mov Disord 2008; 23: 1546-1550.